ImmuneBiotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

ImmuneBiotech General Information

Description

Developer of novel therapeutics designed to target the gut microbiota and the immune system. The company focuses on therapeutic bioactive pharmaceutical products including combinations of probiotics, prebiotics, and proteins, in order to confront a range of inflammatory disorders, such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes, enabling healthcare professionals to prevent and treat autoimmune and other chronic inflammatory condition.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scheelevägen 2
  • Medicon Village
  • 223 81 Lund
  • Sweden
+46 046-25
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • Scheelevägen 2
  • Medicon Village
  • 223 81 Lund
  • Sweden
+46 046-25

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuneBiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 01-Apr-2026 Completed Generating Revenue
10. Later Stage VC 20-Jan-2021 Completed Generating Revenue
9. Angel (individual) 23-Sep-2020 Completed Generating Revenue
8. Later Stage VC 01-Jan-2020 Completed Generating Revenue
7. Grant 30-Sep-2019 Completed Generating Revenue
6. Angel (individual) 24-Jan-2019 Completed Generating Revenue
5. Grant 01-Jan-2019 Completed Generating Revenue
4. Later Stage VC (Series A) Completed Startup
3. Angel (individual) 16-Feb-2018 $313K $313K Completed Startup
2. Accelerator/Incubator Completed Startup
To view ImmuneBiotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ImmuneBiotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmuneBiotech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
I Love Lund Family Office Minority
European Union Government Minority
Angel (individual) Minority
EASME - EU Executive Agency for SMEs Corporation
Lund University University
To view ImmuneBiotech’s complete investors history, request access »

ImmuneBiotech FAQs

  • When was ImmuneBiotech founded?

    ImmuneBiotech was founded in 2013.

  • Where is ImmuneBiotech headquartered?

    ImmuneBiotech is headquartered in Lund, Sweden.

  • What is the size of ImmuneBiotech?

    ImmuneBiotech has 5 total employees.

  • What industry is ImmuneBiotech in?

    ImmuneBiotech’s primary industry is Drug Discovery.

  • Is ImmuneBiotech a private or public company?

    ImmuneBiotech is a Private company.

  • What is ImmuneBiotech’s current revenue?

    The current revenue for ImmuneBiotech is .

  • How much funding has ImmuneBiotech raised over time?

    ImmuneBiotech has raised $2.71M.

  • Who are ImmuneBiotech’s investors?

    I Love Lund, European Union, , EASME - EU Executive Agency for SMEs, and Lund University have invested in ImmuneBiotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process